Europe
The designation is based on data from two Phase I trials, which showed the drug to be safe, demonstrating early efficacy.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
The license and collaboration agreement allows Janssen to use F-star’s proprietary technology in the research, development and commercialization of novel bispecific antibodies.
Biopharma and life sciences companies from across the globe provide updates on their pipelines and business operations.
The CDC has warned that COVID-19 during pregnancy can result in preterm birth and other negative outcomes, including stillbirths.
Investors can take their pick of life sciences companies, with more innovative ideas and treatments being added to pipelines daily. Here’s who brought in the sheaves this week.
The Delta variant is the deadliest variant of the coronavirus, and according to the CDC, this variant has the highest transmission rate yet.
Choosing to exercise its options with a group of research and development partners, the pharma giant will accelerate a promising new C.F. gene therapy.
It proved itself superior to AZD1222 (ChAdOx1-S), the vaccine by Astrazeneca-Oxford, in terms of geometric mean titer for neutralization antibodies.
It was yet another busy week for clinical trial announcements. Take a look.
PRESS RELEASES